Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs

See what CB Insights has to offer

Founded Year



Merger | Acquired

Total Raised


About Contral Pharma

Developer of drugs for the treatment of dependence disorders and glycobiology. In the dependence disorder area the company develops pharmaceutical products and services to offer treatments to conditions with true unmet medical need. The company also focuses on glycobiology and develops anti-infective carbohydrate based pharmaceuticals.

Contral Pharma Headquarter Location

Kappelitie 6

Espoo, 02200,


358 9 4357 50

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.